Rabies Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Rabies Diagnostics Market, By Diagnostic Method

7.1.  Rabies Diagnostics Market, By Diagnostic Method, 2021-2028

7.1.1.    Fluorescent Antibody Test (FAT)

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Immunohistochemical Test

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Amplification Methods

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    Histologic Examination

7.1.4.1.        Market Revenue and Forecast (2016-2028)

7.1.5.    Serology Tests

7.1.5.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Rabies Diagnostics Market, By Technology Method

8.1.  Rabies Diagnostics Market, By Technology Method, 2021-2028

8.1.1.    ELISA/Immunohistochemistry

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Chromatography Techniques

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    PCR

8.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Rabies Diagnostics Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.1.2.    Market Revenue and Forecast, By Technology Method (2016-2028)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.1.3.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.1.4.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.2.2.    Market Revenue and Forecast, By Technology Method (2016-2028)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.2.3.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.2.4.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.2.5.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.2.6.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.3.2.    Market Revenue and Forecast, By Technology Method (2016-2028)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.3.3.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.3.4.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.3.5.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.3.6.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.4.2.    Market Revenue and Forecast, By Technology Method (2016-2028)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.4.3.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.4.4.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.4.5.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.4.6.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.5.2.    Market Revenue and Forecast, By Technology Method (2016-2028)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.5.3.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Diagnostic Method (2016-2028)

9.5.4.2.        Market Revenue and Forecast, By Technology Method (2016-2028)

Chapter 10.  Company Profiles

10.1.              Bio-Rad Laboratories, Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Aviva Systems Biology Corporation

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Merck KGaA

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Demeditec Diagnostics GmbH

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Creative Diagnostics

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Norgen Biotek Corp.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Abbexa Ltd.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Express Biotech International Inc.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              BioNote, Inc.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           MyBioSource.com.

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms